Key Points
- Novanta CFO Robert Buckley sold 9,957 shares on March 16 at an average price of $116.77 for about $1.16M, trimming his stake by 9.34% to 96,616 shares.
- Novanta reported quarterly EPS of $0.91 (beat by $0.03) on revenue of $258.35M (slightly below estimates) and issued FY2026 guidance of 3.50–3.65 EPS and Q1 guidance of 0.75–0.80 EPS.
- Institutional ownership is very high (about 98.35%), with major recent position increases from firms like HSBC, while analysts maintain an average "Hold" rating and a $150 price target.
Novanta Inc. (NASDAQ:NOVT - Get Free Report) CFO Robert Buckley sold 9,957 shares of the firm's stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $116.77, for a total value of $1,162,678.89. Following the transaction, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Robert Buckley also recently made the following trade(s):
- On Friday, February 20th, Robert Buckley sold 1,423 shares of Novanta stock. The shares were sold at an average price of $140.88, for a total value of $200,472.24.
- On Wednesday, January 21st, Robert Buckley sold 1,423 shares of Novanta stock. The shares were sold at an average price of $140.14, for a total value of $199,419.22.
Novanta Stock Down 1.4%
Shares of Novanta stock opened at $119.33 on Thursday. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69. Novanta Inc. has a 52-week low of $98.27 and a 52-week high of $149.95. The company's 50 day moving average price is $135.24 and its 200-day moving average price is $121.21. The stock has a market capitalization of $4.26 billion, a price-to-earnings ratio of 81.73 and a beta of 1.61.
Novanta (NASDAQ:NOVT - Get Free Report) last posted its quarterly earnings results on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.88 by $0.03. The company had revenue of $258.35 million during the quarter, compared to analyst estimates of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same period in the prior year, the business posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities research analysts forecast that Novanta Inc. will post 3.03 EPS for the current year.
Institutional Investors Weigh In On Novanta
Several institutional investors and hedge funds have recently modified their holdings of NOVT. Rockefeller Capital Management L.P. raised its stake in Novanta by 155.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 662 shares of the technology company's stock worth $79,000 after buying an additional 403 shares in the last quarter. Corient Private Wealth LLC bought a new stake in Novanta during the 4th quarter valued at approximately $275,000. Hsbc Holdings PLC grew its holdings in shares of Novanta by 1,355.6% during the 4th quarter. Hsbc Holdings PLC now owns 185,155 shares of the technology company's stock worth $21,964,000 after acquiring an additional 172,435 shares during the period. Invesco Ltd. grew its holdings in shares of Novanta by 9.0% during the 4th quarter. Invesco Ltd. now owns 68,089 shares of the technology company's stock worth $8,102,000 after acquiring an additional 5,600 shares during the period. Finally, Alberta Investment Management Corp bought a new position in shares of Novanta in the 4th quarter worth approximately $1,285,000. 98.35% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on NOVT. Zacks Research upgraded shares of Novanta from a "strong sell" rating to a "hold" rating in a report on Friday, January 16th. Robert W. Baird set a $150.00 price target on Novanta in a research report on Wednesday, February 25th. Finally, Weiss Ratings upgraded Novanta from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Tuesday, January 20th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Novanta currently has an average rating of "Hold" and an average price target of $150.00.
Get Our Latest Stock Report on Novanta
Novanta Company Profile
(
Get Free Report)
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
